Chairman, President & CEO

Chief Financial Officer

Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights

Ablation Technology Market to Worth Over US$ 16.74 Billion by 2034 | Astute Analytica

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS

Change Management Lead, MedSurg Magellan

Boston Scientific is a leader in medical science, dedicated to addressing significant health industry challenges. The Change Management Lead will support the Magellan business transformation program, focusing on deployment communications, stakeholder engagement, and guiding end-user journeys across various teams.

Change Management Lead, Medsurg Magellan in united states (1000+)

Change Management Lead, MedSurg Magellan